BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2016
View Archived Issues
Normalizing standard laboratory mouse husbandry replicates adult human immune traits
Read More
RSPO3 is a potential biomarker of cholangitis
Read More
Brigatinib granted U.S. orphan designation for ALK-, ROS1- or EGFR-positive NSCLC
Read More
Gilead's MAA for Odefsey single tablet regimen receives positive opinion for the treatment of HIV
Read More
Merck & Co. patents PAR1 receptor antagonists
Read More
Daclizumab recommended for approval in E.U.
Read More
Interim results reported from CyTuVax's phase I study of hepatitis B vaccine
Read More
Avibactam/ceftazidime gets positive opinion from CHMP
Read More
MEG3 levels are increased in hypoxia-induced pulmonary hypertension
Read More
Antitumor activity observed in RAS-mutant cancers in phase I study of BGB-283
Read More
Cempra completes rolling NDA submissions for solithromycin in CABP
Read More
Corcept advances selective cortisol modulator CORT-125134 in clinic
Read More
AB Science submits MAA in E.U. for masitinib to treat severe systemic mastocytosis
Read More
AbbVie updates pipeline progress of first quarter 2016
Read More
EPI-743 improves CNS markers of oxidative stress and retinal function in PD
Read More
miR-873's effects on glycine N-methyltransferase can be targeted to reduce liver injury
Read More
FDA approves Nuplazid for hallucinations and delusions associated with Parkinson's disease psychosis
Read More
CHMP backs approval of Imbruvica in CLL
Read More
Marathon Pharmaceuticals discloses phase III results of deflazacort and prednisone for DMD
Read More
Oncurious announces new phase I/IIa study of TB-403 for medulloblastoma
Read More
Medivation rejects Sanofi's offer
Read More
EMA committee backs marketing authorization for Enzepi
Read More
FDA grants emergency use authorization to Quest Diagnostics' Zika virus test
Read More
BAY-1436032 shows promising antitumor activity in vivo
Read More
Bristol-Myers Squibb offers overview of first quarter 2016
Read More